Monday 29 November 2021, 11.00am – 1.00pm
Facilitator: Dr Angela Finch, UNSW Sydney
11.00am – 12.00pm
Innovations in Education from across ASCEPT-Panel Discussion
This session will highlight innovative educational approaches that our members have developed to enhance the teaching of topics that reflect the diversity of pharmacology represented by our special interest groups.
Videos from each speaker will be made available for viewing before the session. Join us for a panel discussion to learn more about fantastic work happening in this space.
Panelists: Dr Iris Lim, Bond University; Dr Nel Karunaratne, Dr Betty Exintaris, Dr Jennifer Irvine, Monash University; Dr Angela Finch, Dr Nicole Jones, UNSW Sydney; Dr Ian Musgrave, University of Adelaide
12.00pm – 12.30pm
Follow-up from challenges and adventures in hybrid teaching mid-year workshop
This session will invite participants to reflect on their experiences with hybrid (online and face to face) teaching and share success and/or failures of different approaches/projects they have tried.
12.30pm – 1.00pm
Education Forum AGM
Drug Discovery workshop: Application of artificial intelligence and computational tools in drug discovery
Facilitators: Dr Katie Leach, Dr Michelle Halls and Assoc Prof Denise Wootten, Monash University
Overview: This workshop is designed to introduce researchers to the core concepts in artificial intelligence (AI) and high-performance computing (HPC), the fundamentals to get started with using AI, and to provide examples of how these approaches can be utilised in pharmacological research and drug discovery.
11.00am – 12:10pm Deep Learning Workshop – Theory and Concepts
Chair: Dr Michelle Halls, Monash University
Presenters: William Maclean, Erika Choong, Ayden Khalil, from Monash DeepNeuron; a student-led non-profit engineering team that promote accessibility of AI and HPC.
12.10pm – 12.40pm Exploiting computational approaches to facilitate G protein-coupled receptor pharmacology and drug discovery.
Chair: Assoc Prof Denise Wootten, Monash University
Alex Hauser, University of Copenhagen
12.40pm – 13.00pm Panel discussion/ Q&A
Moderator: Dr Katie Leach, Monash University
Panel members: Dr Lauren May, Ahn Nguyen, Monash University; William Maclean, Erika Choong, Ayden Khalil, Monash DeepNeuron
Facilitator: Prof Andrew Somogyi, The University of Adelaide
No one and no disease gets left behind – progressing the clinical implementation of pharmacogenomics
11.05am – 11.35am
Translating Pharmacogenomics in Mental Health Care
Assoc Prof Kathy Wu, St Vincent’s Hospital
11.35am – 12.10pm
U-PGx: Design and Netherlands Implementation
Assoc Prof Jesse Swen, Leiden University Medical Center, The Netherlands
12.10pm – 12.25pm
Pharmacogenomic testing: Perception of clinical utility, and enablers and barriers to adoption in Australian hospitals
Dr Sophie Stocker, The University of Sydney
12.25pm – 12.40pm
Closing the Loop: Pharmacogenetics in Australian Pharmacies
Mr Nicholas Haddrick, Honours student, The University of Canberra
12.40pm – 1.00pm
Monday 29 November 2021, 2.00pm – 4.00pm
Facilitators: Dr Betty Exintaris and Assoc Prof Barbara Kemp-Harper, Monash University
The purpose of this workshop will be to hear from professionals in education, industry, government and research who have transitioned from or stayed in research. The format will include individual presentations, a panel discussion and networking in breakout rooms. The speakers are:
• Ms Katie Martin, Policy Officer at the Australian Government Department of Health, Canberra
• Prof Mark Hutchinson, Director of the ARC Centre of Excellence for Nanoscale BioPhotonics, University of Adelaide
• Assoc Prof Tamara Paravicini, STEM College, RMIT University
• Dr Preet Chadha, Senior Medical Manager (Oncology), AstraZeneca
Clinical Pharmacology workshop: To TDM or not to TDM, that is the question!”
Chair: A/Prof Darren Roberts, St Vincent’s Hospital Sydney; University of New South Wales
Presenters: Scientists and Clinicians from Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital Sydney
Overview: This workshop will explore decision-making regarding the use of therapeutic drug monitoring (TDM; or Target Concentration Intervention, TCI) in clinical practice, with a focus on antibiotics.
Part 1: Presentation providing an overview of the topic. Participants will review criteria/characteristics/conditions described in the literature, propose others as needed, and reflect on whether any should be rated of greater or lesser importance.
Part 2: In groups, participants will apply these criteria to the scenario of linezolid, an antibiotic for which TDM is possible, but not currently routine
Part 3: Participants will reflect on findings by each group and consider the question “Does the current evidence support linezolid TDM in routine clinical care?”. Participants will discuss any research questions prompted by these discussions, their priority, and how these can be addressed by the Australasian clinical pharmacology community.